Relevance: primary · Type: event
Confidence100%
At Erlanger Baroness hospital in Chattanooga, anesthesia staff observed a nurse slurring his words and struggling to stay awake while on duty in the surgery center approximately a year ago.
Relevance: primary · Type: event
Confidence100%
The nurse failed a drug test and was subsequently fired.
Relevance: primary · Type: event
Confidence100%
The nurse admitted to having pilfered and abused fentanyl left over after surgeries for months, sometimes daily.
Relevance: supporting · Type: background
Confidence100%
Erlanger Baroness hospital uses Sentri7, an AI-powered medication-monitoring software designed to detect missing drugs faster than humans.
Relevance: primary · Type: event
Confidence100%
According to the Tennessee Board of Nursing consent order, Sentri7 failed to raise alarms for months despite missing drugs and other 'inconsistencies' that 'should have been flagged.'
Relevance: primary · Type: action
Confidence100%
The Tennessee Board of Nursing placed John Stevenson’s license on probation while he underwent drug counseling.
Relevance: primary · Type: event
Confidence100%
John Stevenson settled the case against him by signing the Tennessee Board of Nursing consent order in November.
Relevance: supporting · Type: background
Confidence100%
John Stevenson has not been charged with any crime related to the Erlanger case.
Relevance: supporting · Type: action
Confidence100%
Erlanger Baroness, also referred to as Erlanger Medical Center, declined to comment on its use of Sentri7 or on the diverted drugs.
André Rebelo, spokesperson for the health division at Wolters Kluwer
Relevance: supporting · Type: quote
Confidence100%
André Rebelo, a spokesperson for the health division at Wolters Kluwer, declined to answer questions about what happened at Erlanger but said the company remained 'confident in our software.'
David Rastall, Johns Hopkins Medicine neurologist and AI researcher
Relevance: supporting · Type: quote
Confidence100%
David Rastall, a Johns Hopkins Medicine neurologist and AI researcher, said that because AI technology is heavily proprietary and hospital officials often don't understand how it works, errors can be buried rather than fixed.
David Rastall, Johns Hopkins Medicine neurologist and AI researcher
Relevance: supporting · Type: quote
Confidence100%
David Rastall said, 'The ideal for patients, caregivers, and hospital systems would be, when an AI is found to be making some type of error, that becomes very transparent and public.'
Relevance: supporting · Type: background
Confidence100%
The Drug Enforcement Administration mandates that hospitals confidentially report lost or stolen drugs.
Relevance: supporting · Type: background
Confidence100%
Hospitals are not required to include details about any AI software involved in drug diversion incidents when reporting to state health agencies or the DEA.
Jacob Smith, pharmacist in charge of drug security at Johns Hopkins Medicine
Relevance: supporting · Type: quote
Confidence100%
Jacob Smith, a pharmacist in charge of drug security at Johns Hopkins Medicine, said, 'I've never myself seen these technologies be called out in that specific way.'
Jacob Smith, pharmacist in charge of drug security at Johns Hopkins Medicine
Relevance: supporting · Type: quote
Confidence100%
Jacob Smith said, 'It doesn't make sense to me how you could miss it.'
Terri Vidals, founder of Rxpert Solutions
Relevance: supporting · Type: quote
Confidence100%
Terri Vidals, the founder of Rxpert Solutions, questioned whether the Erlanger case was the result of user error instead of software malfunction.
Terri Vidals, founder of Rxpert Solutions
Relevance: supporting · Type: quote
Confidence100%
Terri Vidals said, 'This is the most basics of basics for this software. I find it interesting that they're saying it wasn't flagged by the software. I think there's maybe more to that story.'
Relevance: supporting · Type: event
Confidence100%
The apparent Sentri7 failure at Erlanger was revealed in a routine release of state disciplinary orders by the Tennessee Department of Health in December.
Relevance: supporting · Type: action
Confidence100%
Bill Christian, a spokesperson for the Tennessee Department of Health and Board of Nursing, declined to comment on the Erlanger case or Sentri7.
Relevance: supporting · Type: event
Confidence100%
In response to public records requests, the Tennessee Department of Health and the Tennessee Health Facilities Commission each said they possessed no other documents about the apparent Sentri7 failure at Erlanger.
Relevance: supporting · Type: event
Confidence100%
Erlanger spokesperson Charlie Milburn said in a March email that the hospital’s legal team was debating whether to release a written statement about its use of Sentri7, and later declined to answer any questions.
Kristy Drollinger, Wolters Kluwer executive
Relevance: supporting · Type: quote
Confidence100%
Kristy Drollinger, a Wolters Kluwer executive, said Sentri7 monitors about 60 'attributions of risk' that identify red flags for further investigation by hospital employees.
Kristy Drollinger, Wolters Kluwer executive
Relevance: supporting · Type: quote
Confidence100%
Kristy Drollinger said, 'It's pretty scary. Every health system, every health facility, has had diversion at some point — and probably has it now.'
Relevance: supporting · Type: background
Confidence100%
Drug diversion is estimated to occur at least once among as many as 15% of all healthcare workers, according to the nonprofit Healthcare Diversion Network.
Relevance: supporting · Type: background
Confidence100%
Drug diversion has been linked to at least 13 disease outbreaks causing more than 200 infections, mostly of hepatitis C, since 1985, according to the Centers for Disease Control and Prevention.
Relevance: supporting · Type: background
Confidence100%
An additional 700 hospitals use Sentri7 Clinical Surveillance programs, which can include its drug diversion software, according to Wolters Kluwer.
Jacob Smith, pharmacist in charge of drug security at Johns Hopkins Medicine
Relevance: supporting · Type: quote
Confidence100%
Jacob Smith said hospitals purchase 'expensive technologies' like Sentri7 because a disastrous diversion case could result in a multimillion-dollar fine from the DEA.
Jacob Smith, pharmacist in charge of drug security at Johns Hopkins Medicine
Relevance: supporting · Type: quote
Confidence100%
Jacob Smith said, 'They don't promise a return on investment. They promise cost avoidance.'
Relevance: primary · Type: background
Confidence100%
John Stevenson is identified in the Tennessee Board of Nursing order as a nurse anesthetist.
forum Comments (0)
No comments yet. Be the first to comment.